University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...
This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...
ETHealthworld.com brings latest bdr pharma news, views and updates from all top sources for the Indian Health industry.
AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with idiopathic pulmonary fibrosis (IPF) BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- ...
BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- Avalyn, a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, ...
There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.
BOSTON, March 25, 2026 (GLOBE NEWSWIRE)-- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm ...
Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...
A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in ...
The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results